Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thrombocythemia, Essential × Resistance Training × Clear all

Sponsor

Conditions

Motor Activity 6 Polycystic Ovary Syndrome 2 Obesity 2 Diabetes Mellitus 2 Stroke 1 Sedentary Behavior 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteoporosis 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lung Neoplasms 1 Limb-girdle muscular dystrophy, type 2C 1 Leukemia, Myeloid, Acute 1 Kidney Diseases 1 Insulin Resistance 1 Hypertension 1 Heart Failure 1 Frailty 1 Endometrial Neoplasms 1 Diabetes Mellitus, Type 2 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Body Weight 1 Arthritis 1

Interventions

fludarabine phosphate 15 Whole-Body Irradiation 9 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 Cyclophosphamide 8 Busulfan 8 Tacrolimus 7 Cyclosporine 5 fludarabine 4 Methotrexate 4 Antilymphocyte Serum 4 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 peginterferon alfa-2a 2 givinostat hydrochloride 2 givinostat 2 Radiotherapy 2 Melphalan 2 Etoposide 2 Carboplatin 2 veliparib 1 thymoglobulin 1 sonidegib 1 pomalidomide 1 merphos 1 bomedemstat 1 anagrelide 1 Transplantation 1 Topotecan 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡